 |
市場調査レポート
商品コード
1441228
睡眠障害の世界市場規模、シェア、成長分析、睡眠障害のタイプ別、診断方法別 - 産業予測2023～2030年Global Sleep Disorder Market Size, Share, Growth Analysis, By Type of Sleep Disorder(Insomnia, Sleep Apnea), By Diagnosis Method(Polysomnography (PSG), Actigraphy) - Industry Forecast 2023-2030 |
||||||
| 睡眠障害の世界市場規模、シェア、成長分析、睡眠障害のタイプ別、診断方法別 - 産業予測2023～2030年 |
|
出版日: 2024年02月22日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
世界の睡眠障害の市場規模は、2022年に225億米ドルとなり、予測期間中（2024～2031年）のCAGRは12%で、2023年の26億1,000万米ドルから、2031年までに153億2,000万米ドルに成長する見通しです。
世界の睡眠障害市場は、睡眠の質と持続時間に影響を及ぼす様々な睡眠関連疾患の診断、治療、管理に関連します。全体的な健康と幸福のために睡眠が重要であるという認識が高まるにつれ、この市場は大きな注目を集めています。睡眠障害には、不眠症、睡眠時無呼吸症候群、レストレスレッグス症候群、ナルコレプシーなど、さまざまな疾患が含まれます。市場を牽引する要因はいくつかあります。ライフスタイルの変化、ストレスレベルの上昇、睡眠関連疾患の流行とともに、睡眠障害に対する認識が高まり、診断と治療に対する需要が急増しています。技術の進歩により、ウェアラブルデバイスや遠隔医療ソリューションなどの革新的な診断ツールや治療オプションが生まれ、市場の成長に寄与しています。さらに、睡眠障害の影響を受けやすい高齢者人口の拡大、睡眠問題を悪化させる可能性のある肥満や糖尿病などの慢性疾患の有病率の増加が、効果的な介入に対する需要をさらに煽っています。その結果、製薬会社、医療機器メーカー、ヘルスケアプロバイダーは、睡眠障害の改善された治療法や解決策を提供するために研究開発に投資しています。睡眠が健康全般に及ぼす影響に対する理解が深まり、睡眠関連の課題に直面する個人の多様なニーズに対応する取り組みが進んでいることから、睡眠障害市場は今後も上昇基調を維持すると予想されます。
目次
エグゼクティブサマリー
- 市場概要
- 運命の輪
調査手法
- 情報調達
- 二次・一次情報源
- 市場規模の推定
- 市場の前提条件と制限
親市場の分析
- 市場概要
- 市場規模
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
主な市場の考察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 貿易分析
- スタートアップ分析
- 原材料の分析
- イノベーションマトリクス
- パイプライン製品の分析
- マクロ経済指標
- 主な投資の分析
- 主な成功要因
- 競合の程度
市場力学と見通し
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 規制情勢
- ポーターの分析
- 将来の混乱についての特別な考察
睡眠障害の世界市場：睡眠障害のタイプ別
- 市場概要
- 不眠症
- 睡眠時無呼吸
- レストレスレッグス症候群（RLS）
- ナルコレプシー
- 睡眠時随伴症（夢遊病・夜驚症など）
- 概日リズム障害
睡眠障害の世界市場：診断方法別
- 市場概要
- 睡眠ポリグラフィー（PSG）
- アクティグラフィー
- 在宅睡眠時無呼吸検査（HSAT）
- 複数睡眠潜時テスト（MSLT）
- 脳波検査（EEG）
- その他
睡眠障害の世界市場規模：地域別
- 市場概要
- 北米
- 米国
- カナダ
- 欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他欧州地域
- アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋
- ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
- 中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域
競合情勢
- 上位5社の比較
- 主要企業の市場ポジショニング（2021年）
- 主な市場企業が採用した戦略
- 主要成功戦略
- 市場における最近の活動
- 主要企業の市場シェア（2021年）
主要企業プロファイル
- ResMed Inc.
- Philips Healthcare
- Fisher & Paykel Healthcare
- Inspire Medical Systems
- Sleep Number Corporation
- Koninklijke Philips NV.
- Natus Medical Incorporated
- Compumedics Limited
- Becton, Dickinson and Company
- Itamar Medical Ltd.
- Nihon Kohden Corporation
- Medtronic plc
- DeVilbiss Healthcare
- Drive DeVilbiss Healthcare
- Cardinal Health
- NovaSom, Inc.
- Advanced Brain Monitoring
- SleepMed Inc.
- Sefam
- BMC Medical Co., Ltd.
Global Sleep Disorder Market size was valued at USD 22.50 Billion in 2022 and is poised to grow from USD 2.61 Billion in 2023 to USD 15.32 Billion by 2031, at a CAGR of 12% during the forecast period (2024-2031).
The Global Sleep Disorder Market pertains to the diagnosis, treatment, and management of various sleep-related conditions that affect the quality and duration of sleep. With the increasing recognition of the importance of sleep for overall health and well-being, this market has garnered significant attention. Sleep disorders encompass a range of conditions, including insomnia, sleep apnea, restless legs syndrome, narcolepsy, and more. Several factors drive the market. The rising awareness of sleep disorders, along with changing lifestyles, increased stress levels, and the prevalence of sleep-related medical conditions, has spurred demand for diagnosis and treatment. Technological advancements have resulted in innovative diagnostic tools and treatment options, such as wearable devices and telemedicine solutions, contributing to market growth. Moreover, the expanding geriatric population, more susceptible to sleep disorders, and the increasing prevalence of obesity and chronic conditions like diabetes, which can exacerbate sleep issues, further fuel the demand for effective interventions. Consequently, pharmaceutical companies, medical device manufacturers, and healthcare providers are investing in research and development to offer improved therapies and solutions for sleep disorders. The sleep disorder market is expected to maintain its upward trajectory due to the growing understanding of the impact of sleep on overall health and ongoing efforts to address the diverse needs of individuals facing sleep-related challenges.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Sleep Disorder Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to get the final quantitative and qualitative data.
Global Sleep Disorder Market Segmental Analysis
The global sleep disorder market is segmented by Type of Sleep Disorder, Diagnosis Method, End-use and Region. Based on Type of sleep disorder the market is Insomnia, Sleep Apnea, Restless Legs Syndrome (RLS), Narcolepsy, Parasomnias (sleepwalking, night terrors, etc.), and Circadian Rhythm Disorders. Based on Diagnosis Method the market is segmented as, Polysomnography (PSG), Actigraphy, Home Sleep Apnea Test (HSAT), Multiple Sleep Latency Test (MSLT), Electroencephalography (EEG), Others. Based on End-User the segments are segmented as Hospitals and Clinics, Sleep Centers, Homecare Settings, Diagnostic Laboratories. Regional the market is segmented as, North America, Asia Pacific, Latin America, and Middle East & Africa (MEA)
Drivers of the Global Sleep Disorder Market
The increasing awareness of the adverse health consequences associated with sleep disorders serves as a significant driver. Greater education and information dissemination through various channels are encouraging individuals to proactively seek diagnosis and treatment for their sleep-related concerns.
Ongoing advancements in diagnostic tools and treatment options, including the development of portable sleep monitoring devices and telemedicine solutions, contribute to market growth by enhancing accessibility and convenience in the diagnosis and treatment of sleep disorders.
Restraints in the Global Sleep Disorder Market
Despite the growing awareness, there is still a lingering stigma surrounding sleep disorders, which causes some individuals to refrain from seeking professional help. Furthermore, in certain regions, a lack of awareness poses a barrier to early diagnosis and treatment.
In specific areas, health insurance may not cover sleep disorder treatments and diagnostics, acting as a deterrent for individuals seeking proper care due to financial concerns.
Market Trends of the Global Sleep Disorder Market
The utilization of telemedicine and remote monitoring solutions has experienced a significant increase, allowing individuals to receive diagnosis and treatment for sleep disorders from their residences. This surge has been propelled by the COVID-19 pandemic, prompting the emergence of virtual sleep clinics and wearable technologies for remote sleep tracking.
Another notable trend is the incorporation of artificial intelligence (AI) and machine learning (ML) into Computer-Aided Engineering (CAE) software. These technologies enhance the accuracy of simulations, facilitate quicker optimization, and automate repetitive tasks, thereby improving the efficiency and precision of engineering analyses.
Table of Contents
Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Global Sleep Disorder Market by Type of Sleep Disorder
- Market Overview
- Insomnia
- Sleep Apnea
- Restless Legs Syndrome (RLS)
- Narcolepsy
- Parasomnias (sleepwalking
- night terrors
- etc.)
- and Circadian Rhythm Disorders.
Global Sleep Disorder Market by Diagnosis Method
- Market Overview
- Polysomnography (PSG)
- Actigraphy
- Home Sleep Apnea Test (HSAT)
- Multiple Sleep Latency Test (MSLT)
- Electroencephalography (EEG)
- and Others
Global Sleep Disorder Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- ResMed Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Philips Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Fisher & Paykel Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Inspire Medical Systems
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sleep Number Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Koninklijke Philips NV.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Natus Medical Incorporated
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Compumedics Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Becton, Dickinson and Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Itamar Medical Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Nihon Kohden Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Medtronic plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- DeVilbiss Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Drive DeVilbiss Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cardinal Health
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- NovaSom, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Advanced Brain Monitoring
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- SleepMed Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sefam
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BMC Medical Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
